Jawbone's recent $300M investment from BlackRock was debt, not equity
Jawbone Gets a Loan and a Leash — Jawbone, the San Francisco maker of wearable technology, recently got a hefty $300 million investment from BlackRock, the largest and one of the most trusted asset management companies in the world.
Context & Ripple Effects
When Jawbone's $300M raise from BlackRock closed in April, it was reported as an investment round at a roughly $3B valuation ($300M investment round). This piece corrects the record: the money was debt, meaning BlackRock is a creditor with a claim on the company, not a shareholder betting on its upside.
The distinction turned out to be diagnostic. Within months Jawbone raised a follow-on all-equity round at $1.5B — half its peak valuation, pivoted toward a B2B model for clinics and health professionals, and was ultimately liquidated, with founder Hosain Rahman moving to Jawbone Health Hub. Debt at the peak was an early marker of the slide.
First-order effects
- BlackRock holds repayment rights rather than equity upside, and per the headline gets 'a leash' — contractual leverage over how Hosain Rahman runs Jawbone that a straight $3B valuation round would not have conferred.
Second-order effects
- Follow-on investors priced off the debt signal: the next round came in as all-equity but at $1.5B, half the valuation attached to the original announcement, with president Sameer Samat returning to Google.
Third-order effects
- When a consumer-hardware startup's growth story stalls, late-stage capital shifts from equity to structured debt first and liquidation follows if the pivot fails — Jawbone's path from BlackRock loan to shutdown shows lenders, not VCs, marking the end of the private-valuation cycle.
The trend: Late-stage private tech companies that outrun their fundamentals increasingly turn to debt financing, which converts a valuation problem into a solvency problem when the turnaround stalls.